The Clorox Company (NYSE:CLX) Stock Position Lifted by Lbp Am Sa

Lbp Am Sa boosted its stake in The Clorox Company (NYSE:CLXFree Report) by 212.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 84,122 shares of the company’s stock after buying an additional 57,228 shares during the quarter. Lbp Am Sa owned approximately 0.07% of Clorox worth $13,662,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Brooklyn Investment Group raised its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new position in Clorox during the third quarter valued at about $27,000. Continuum Advisory LLC lifted its position in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc bought a new stake in shares of Clorox during the 4th quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in shares of Clorox in the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 0.3 %

Shares of CLX stock opened at $147.32 on Friday. The stock has a market cap of $18.15 billion, a P/E ratio of 40.25, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a fifty day moving average price of $154.20 and a 200 day moving average price of $160.17. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the company earned $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.31%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is 133.33%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CLX. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Barclays upped their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Wells Fargo & Company lifted their price objective on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Finally, StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $159.62.

Get Our Latest Research Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.